Delivery Technologies for Cancer Immunotherapy
This review published in Nature Reviews Drug Discovery (co-authored by Rachel Riley, Carl June, Bob Langer, and Mike Mitchell) describes recent research advances, challenges, and opportunities for integrating delivery technologies into cancer immunotherapy.
Videos of research talks from the symposium "Breakthrough Cancer Nanotechnologies" are now available!
Click here to view talks from leading investigators in cancer nanomedicine as well as the panel discussion on "Translation of Nanomedicine to Patients."
Meet the 2018-2019 Convergence Scholars!
The Convergence Scholars Program provides postdoctoral trainees at the Marble Center and the Center for Precision Cancer Medicine with opportunities to further their experiences and skills beyond the research laboratory space. Click here to learn more.
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
The cytokine-delivery system developed by Tang et al. releases cytokines specifically at the tumor after T cells recognize a tumor antigen. Click here to learn more. Illustration by Yutao Dong.
Dr. Angela Belcher Commands a Virus to Hunt a Deadly Cancer
Dr. Angela Belcher engineers nanoparticles to light up tiny tumors that doctors can’t see. Click here to learn more. Illustration by Agata Nowicka; original article by T. Ready, Neo.Life.
Breakthrough Cancer Nanotechnologies
On June 15, 2018, MIT’s Koch Institute for Integrative Cancer Research will present its 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies. CLICK HERE TO REGISTER NOW!
Dr. Bhatia Speaks at the Annual National Academy of Sciences Meeting
Dr. Sangeeta Bhatia spoke at this year's 155th National Academy of Sciences meeting. Her talk "It's a Small World After All: Tiny Technologies and Liver Disease" can be watched here.
Celebrating National Nanotechnology Day
Dr. Sangeeta Bhatia's commentary for National Nanotechnology Day featured by the National Academy of Sciences. Click here to read the commentary.
Dr. Bob Langer receives the 2017 Kabiller Prize in Nanoscience and Nanomedicine from Northwestern
Dr. Robert S. Langer, David H. Koch Institute Professor at MIT and member of the Marble Center for Cancer Nanomedicine, is the recipient of the $250,000 Kabiller Prize in Nanoscience and Nanomedicine from Northwestern. The prize recognizes the people designing the technologies that will drive innovation in nanomedicine and also to educate others as to the field’s great promise for helping society. Click here for the press release.
Converging on cancer at the nanoscale
Marking its first anniversary, the Koch Institute’s Marble Center for Cancer Nanomedicine goes full steam ahead. See the article in MIT News here.
Drs. Belcher, Bhatia, and Hammond are innovating at the tiniest scale—developing tools to see, target and kill cancer cells before they can cause any harm. See article here.
Robert Langer, The Delivery Man
The downfall of many drugs is that they are not taken regularly or as prescribed. Robert Langer has developed a polymer that could solve this problem. See article here. Photo credit: Nick D Burton; original article by Kathryn Nave from WIRED Magazine.
Image gallery for National Nanotechnology Day
In honor of the first annual National Nanotechnology Day, the Koch Institute for Integrative Cancer Research at MIT presents an interactive peek into how researchers across the MIT campus are using nanomaterials to explore and improve the world. Source: The Koch Institute for Integrative Cancer Research at MIT.
The Marble Center for Cancer Nanomedicine aims to galvanize the MIT research community in efforts to have an indelible impact on cancer diagnosis and care.